Corporate
Pharming Guides to $405M-$425M Revenue at 2026 Investor Day, Eyes Two Billion-Dollar Pipeline Programs
6h ago
You're signed outSign in or to get full access.
Pharming Group (PHAR) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Pharming Group.
Q3 2025
Nov 6, 2025
Q2 2025
Jul 31, 2025
Q1 2025
May 8, 2025
Q4 2024
Mar 13, 2025
Q3 2024
Oct 24, 2024
H1 2024
Aug 1, 2024
Q1 2024
May 8, 2024